(redirected from Schizoaffective disorder)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to Schizoaffective disorder: borderline personality disorder
References in periodicals archive ?
A recent Spanish functional magnetic resonance brain imaging study demonstrated that schizoaffective disorder exhibits features that more closely resemble those of bipolar disorder than schizophrenia, including the finding that patients in clinical remission show failure of deactivation in the medial frontal gyrus, compared with healthy controls, Dr.
Therefore, the unmet need for a safer and more effective alternative treatment for schizophrenia and schizoaffective disorder is enormous.
The first chapter outlines a historical, international perspective on the controversies related to definitions and theoretical underpinnings of schizoaffective disorder.
Treatment of these four conditions were limited under prior law which offered full coverage only for specific biologically-based mental health conditions including schizophrenia, schizoaffective disorder, major depressive disorder, bipolar disorder, paranoia and other psychotic disorders, obsessive-compulsive disorder, panic disorder, delirium and dementia and affective disorder.
He was diagnosed with bipolar disorder and, later, schizoaffective disorder.
Brendan Burke, defending, told the court Riding suffersfrom schizoaffective disorder.
Adults tend to have bipolar disorder, psychosis, or schizoaffective disorder, he said.
Research psychiatrists have evaluated lithium as a treatment for a variety of psychiatric disorders, including schizophrenia, schizoaffective disorder, alcoholism, premenstrual depression, and periodic aggressive and explosive behavior.
a privately held drug discovery and development company, today announced enrollment of patients in its phase 2 clinical study of RP503 for schizophrenia and schizoaffective disorder.
Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for the treatment of schizophrenia in adults and adolescents (12 -- 17 years of age) in addition to schizoaffective disorder as monotherapy and as an adjunct to mood stabilizers and/or antidepressants in adults.
It helps adults with schizophrenia, schizoaffective disorder, bipolar disorder, major depression and other forms of serious mental illness.